Estrategias Combinadas en Inmunoterapia Traslacional
ITC
Essen University Hospital
Essen, AlemaniaEssen University Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (8)
2024
-
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors
Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 3
2023
-
Reply to letter to the editor “Bureaucracy or Streamlining the Rules in “Good Clinical Practice (GCP)” - Has Equipoise Occurred?” by H. K. Kotikonda, V. G. Jonnalagadda and S. R. Venna
Annals of Oncology
-
Streamlining clinical research: an ESMO awareness call to improve sponsoring and monitoring of clinical trials
Annals of Oncology, Vol. 34, Núm. 1, pp. 70-77
2022
-
Central Role of the Antigen-Presentation and Interferon-γ Pathways in Resistance to Immune Checkpoint Blockade
Annual Review of Cancer Biology, Vol. 6, pp. 85-102
2020
2019
-
Comparison of six commercial serum exosome isolation methods suitable for clinical laboratories. Effect in cytokine analysis
Clinical Chemistry and Laboratory Medicine, Vol. 57, Núm. 10, pp. 1539-1545
2015
-
Future perspectives in melanoma research: Meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014
Journal of Translational Medicine, Vol. 13, Núm. 1
2014
-
Future perspectives in melanoma research: Meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013
Journal of Translational Medicine, Vol. 12, Núm. 1